Recombinant Human PRSS12 Protein，His

PRSS12, also known as tumor-associated trypsinogen, is a serine protease that plays a crucial role in various physiological and pathological processes, particularly in cancer biology. Researchers have identified PRSS12 as a potential biomarker for several types of cancers due to its altered expression patterns in tumor tissues compared to normal tissues. As a serine protease, PRSS12 is involved in the activation of other proteolytic enzymes and signaling pathways, influencing cell proliferation, migration, and invasion—all critical factors in tumor development and progression. The study of PRSS12 has garnered attention for its potential to enhance our understanding of cancer mechanisms and for its utility in diagnostic and therapeutic applications. Recent advancements in recombinant protein technology have enabled the production of PRSS12 in significant quantities, facilitating detailed biochemical and structural studies. By investigating its enzymatic activity and substrate specificity, researchers aim to unravel the functional roles of PRSS12 in different cellular contexts. Furthermore, the development of PRSS12-targeted therapies could open new avenues for innovative cancer treatment strategies, focusing on disrupting its activity or mitigating its effects on tumor cell behavior. Given the critical implications of PRSS12 in tumor biology, ongoing research is essential to fully elucidate its role and therapeutic potential, paving the way for future clinical applications.